- Home
- LPTX vs QH Comparison
LPTX vs QH Comparison
Compare LPTX & QH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPTX
- QH
- Stock Information
- Founded
- LPTX 2011
- QH 2012
- Country
- LPTX United States
- QH China
- Employees
- LPTX N/A
- QH N/A
- Industry
- LPTX Biotechnology: Biological Products (No Diagnostic Substances)
- QH Business Services
- Sector
- LPTX Health Care
- QH Consumer Discretionary
- Exchange
- LPTX Nasdaq
- QH Nasdaq
- Market Cap
- LPTX 119.6M
- QH 134.5M
- IPO Year
- LPTX N/A
- QH 2020
- Fundamental
- Price
- LPTX $0.39
- QH $1.48
- Analyst Decision
- LPTX Buy
- QH
- Analyst Count
- LPTX 3
- QH 0
- Target Price
- LPTX $8.50
- QH N/A
- AVG Volume (30 Days)
- LPTX 321.2K
- QH 21.4K
- Earning Date
- LPTX 05-12-2025
- QH 04-02-2025
- Dividend Yield
- LPTX N/A
- QH N/A
- EPS Growth
- LPTX N/A
- QH N/A
- EPS
- LPTX N/A
- QH N/A
- Revenue
- LPTX N/A
- QH $493,471,493.00
- Revenue This Year
- LPTX N/A
- QH N/A
- Revenue Next Year
- LPTX N/A
- QH N/A
- P/E Ratio
- LPTX N/A
- QH N/A
- Revenue Growth
- LPTX N/A
- QH N/A
- 52 Week Low
- LPTX $0.39
- QH $0.25
- 52 Week High
- LPTX $4.79
- QH $2.27
- Technical
- Relative Strength Index (RSI)
- LPTX 18.56
- QH 54.33
- Support Level
- LPTX $0.40
- QH $1.36
- Resistance Level
- LPTX $0.46
- QH $1.54
- Average True Range (ATR)
- LPTX 0.03
- QH 0.09
- MACD
- LPTX 0.06
- QH 0.00
- Stochastic Oscillator
- LPTX 0.00
- QH 41.38
About LPTX Leap Therapeutics Inc.
Leap Therapeutics Inc is in developing targeted antibody therapies for cancer treatment, focusing on inhibiting tumor-promoting pathways, targeting cancer-specific cell surface molecules, and activating the immune system against cancer cells. The company's lead program, DKN-01, targets Dickkopf-related protein 1 (DKK1) and is in clinical trials for esophagogastric, gynecologic, and colorectal cancers. Their second program, FL-301, targets Claudin18.2-expressing cells. Additionally, the company has two preclinical antibody programs, FL-302 and FL-501, aimed at developing transformative cancer treatments. Operating as a single segment, the company's sole focus is on developing innovative drugs to address unmet needs in cancer therapy. .
About QH Quhuo Limited American Depository Shares
Quhuo Ltd is a gig economy platform in China. The company provides tech-enabled, end-to-end operational solutions to consumer service businesses in industries with e-commerce exposure, including food delivery, ride-hailing, housekeeping, bike-sharing, and other services. The company generates revenue predominantly from service fees paid by its industry customers, and to a lesser extent, from rental fees under its car leasing agreements with drivers engaged in the ride-hailing solutions. It derives all of its revenue from the PRC. The company's revenues are categorized into On-demand delivery solutions; Mobility service solutions; Housekeeping solutions and other services. The On-demand delivery solutions generate key revenue for the firm.